Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [8]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 28543-1-AP - Provider product page
- Provider
- Proteintech Group
- Product name
- Integrin Beta 5 antibody
- Antibody type
- Polyclonal
- Description
- Integrin Beta 5 antibody (Cat. #28543-1-AP) is a rabbit polyclonal antibody that shows reactivity with Human and has been validated for the following applications: WB,ELISA.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Human Seminal Extracellular Vesicles Enhance Endometrial Receptivity Through Leukemia Inhibitory Factor.
Atp6v1h Deficiency Blocks Bone Loss in Simulated Microgravity Mice through the Fos-Jun-Src-Integrin Pathway.
hUC-MSCs-derived MFGE8 ameliorates locomotor dysfunction via inhibition of ITGB3/ NF-κB signaling in an NMO mouse model.
Pan-cancer proteogenomics expands the landscape of therapeutic targets.
Upregulation of CSNK1A1 induced by ITGB5 confers to hepatocellular carcinoma resistance to sorafenib in vivo by disrupting the EPS15/EGFR complex.
Fibronectin type III domain-containing 5 improves aging-related cardiac dysfunction in mice.
In Vivo Visualized Tracking of Tumor-Derived Extracellular Vesicles Using CRISPR-Cas9 System.
MFGE8 mitigates brain injury in a rat model of SAH by maintaining vascular endothelial integrity via TIGβ5/PI3K/CXCL12 signaling.
Wang H, Lin Y, Chen R, Zhu Y, Wang H, Li S, Yu L, Zhang K, Liu Y, Jing T, Sun F
Endocrinology 2024 Mar 29;165(5)
Endocrinology 2024 Mar 29;165(5)
Atp6v1h Deficiency Blocks Bone Loss in Simulated Microgravity Mice through the Fos-Jun-Src-Integrin Pathway.
Zhao Z, Wang X, Ma Y, Duan X
International journal of molecular sciences 2024 Jan 4;25(1)
International journal of molecular sciences 2024 Jan 4;25(1)
hUC-MSCs-derived MFGE8 ameliorates locomotor dysfunction via inhibition of ITGB3/ NF-κB signaling in an NMO mouse model.
Xu H, Jiang W, Li X, Jiang J, Afridi SK, Deng L, Li R, Luo E, Zhang Z, Huang YA, Cui Y, So KF, Chen H, Qiu W, Tang C
NPJ Regenerative medicine 2024 Jan 20;9(1):4
NPJ Regenerative medicine 2024 Jan 20;9(1):4
Pan-cancer proteogenomics expands the landscape of therapeutic targets.
Savage SR, Yi X, Lei JT, Wen B, Zhao H, Liao Y, Jaehnig EJ, Somes LK, Shafer PW, Lee TD, Fu Z, Dou Y, Shi Z, Gao D, Hoyos V, Gao Q, Zhang B
Cell 2024 Aug 8;187(16):4389-4407.e15
Cell 2024 Aug 8;187(16):4389-4407.e15
Upregulation of CSNK1A1 induced by ITGB5 confers to hepatocellular carcinoma resistance to sorafenib in vivo by disrupting the EPS15/EGFR complex.
Gu L, Jin X, Liang H, Yang C, Zhang Y
Pharmacological research 2023 Jun;192:106789
Pharmacological research 2023 Jun;192:106789
Fibronectin type III domain-containing 5 improves aging-related cardiac dysfunction in mice.
Hu C, Zhang X, Hu M, Teng T, Yuan YP, Song P, Kong CY, Xu SC, Ma ZG, Tang QZ
Aging cell 2022 Mar;21(3):e13556
Aging cell 2022 Mar;21(3):e13556
In Vivo Visualized Tracking of Tumor-Derived Extracellular Vesicles Using CRISPR-Cas9 System.
Ye Y, Shi Q, Yang T, Xie F, Zhang X, Xu B, Fang J, Chen J, Zhang Y, Li J
Technology in cancer research & treatment 2022 Jan-Dec;21:15330338221085370
Technology in cancer research & treatment 2022 Jan-Dec;21:15330338221085370
MFGE8 mitigates brain injury in a rat model of SAH by maintaining vascular endothelial integrity via TIGβ5/PI3K/CXCL12 signaling.
Wang J, Wang Y, Zuo Y, Duan J, Pan A, Li JM, Yan XX, Liu F
Experimental brain research 2021 Jul;239(7):2193-2205
Experimental brain research 2021 Jul;239(7):2193-2205
No comments: Submit comment
No validations: Submit validation data